Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Phytopharm opens new facility for manufacture of antiobesity drug

April 16, 1999

Jenapharm's scavestrogen is more potent than estrogen in preventing atherosclerosis

April 16, 1999

Presence of GHRH receptor is essential for response to treatment with GHRPs

April 16, 1999

Estrogen/antiandrogenic progesterone combination for hirsutism: efficacy of long-term Rx

April 16, 1999

New series of osteogenesis-promoting agents developed at Taisho

April 16, 1999

Preclinical and clinical results support efficacy of Trovert in treatment of acromegaly

April 16, 1999

U.K. team develops novel male contraceptive methodology

April 16, 1999

Celtrix and Elan form joint venture for osteoporosis therapy

April 15, 1999

Orquest's bone substitute product approved in E.C.

April 14, 1999

Novel Roche peptides useful for bone disorders

April 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...